Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Return on Sales (2021 - 2025)

Historic Return on Sales for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to 0.12%.

  • Burning Rock Biotech's Return on Sales rose 1500.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2%, marking a year-over-year increase of 6300.0%. This contributed to the annual value of 0.65% for FY2024, which is 5600.0% up from last year.
  • Latest data reveals that Burning Rock Biotech reported Return on Sales of 0.12% as of Q3 2025, which was up 1500.0% from 0.06% recorded in Q2 2025.
  • Over the past 5 years, Burning Rock Biotech's Return on Sales peaked at 0.06% during Q2 2025, and registered a low of 2.0% during Q2 2022.
  • Over the past 5 years, Burning Rock Biotech's median Return on Sales value was 1.32% (recorded in 2023), while the average stood at 1.1%.
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -9100bps in 2021, then soared by 11100bps in 2023.
  • Quarter analysis of 5 years shows Burning Rock Biotech's Return on Sales stood at 1.72% in 2021, then increased by 13bps to 1.49% in 2022, then rose by 11bps to 1.32% in 2023, then skyrocketed by 58bps to 0.56% in 2024, then soared by 78bps to 0.12% in 2025.
  • Its Return on Sales was 0.12% in Q3 2025, compared to 0.06% in Q2 2025 and 0.1% in Q1 2025.